TY  - JOUR

T1  - Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.

JO  - Health technology assessment (Winchester, England)

PY  - 2004/06/01

AU  - Tappenden P

AU  - Chilcott JB

AU  - Eggington S

AU  - Oakley J

AU  - McCabe C

ED  - 

VL  - 8

IS  - 27

Y2  - 2025/10/31

ER  -